Table 16, Subcutaneous Injection: Patients with Adverse Events

Alexander Tsertsvadze; Fatemeh Yazdi; Howard A Fink; Roderick MacDonald; Tim J Wilt; Karla Soares‐Weiser; Anthony J Bella; Dan Deforge; Chantelle Garritty; Mohammed Ansari; Margaret Sampson; Raymond Daniel; David Moher

Article2009

Table 14, Intracavernosal Injection: Patients with Adverse Events

Alexander Tsertsvadze, Fatemeh Yazdi, Howard A Fink, Roderick MacDonald, Tim J Wilt, Karla Soares‐Weiser, Anthony J Bella, Dan Deforge, Chantelle Garritty, Mohammed Ansari, Margaret Sampson, Raymond Daniel, David Moher

Article2009

Table 26, Testosterone Treatment: Patients with Adverse Events

Howard A Fink, Roderick MacDonald, Tim J Wilt, Karla Soares‐Weiser, Anthony J Bella, Dan Deforge, Chantelle Garritty, Mohammed Ansari, Margaret Sampson, Raymond Daniel, David Moher, Alexander Tsertsvadze, Fatemeh Yazdi

Article2009

Table 19, Intra-urethral Treatment: Patients with Adverse Events

Alexander Tsertsvadze, Fatemeh Yazdi, Howard A Fink, Roderick MacDonald, Tim J Wilt, Karla Soares‐Weiser, Anthony J Bella, Dan Deforge, Chantelle Garritty, Mohammed Ansari, Margaret Sampson, Raymond Daniel, David Moher

Article2009

Table 27, Miscellaneous Treatments: Efficacy and Adverse Events

Fatemeh Yazdi, Howard A Fink, Roderick MacDonald, Tim J Wilt, Karla Soares‐Weiser, Anthony J Bella, Dan Deforge, Chantelle Garritty, Mohammed Ansari, Margaret Sampson, Raymond Daniel, David Moher, Alexander Tsertsvadze

Dataset

Supplementary Table 4 from Body Composition, Relative Dose Intensity, and Adverse Events Among Patients with Colon Cancer

En Cheng, Bette J. Caan, Peggy M. Cawthon, William J. Evans, Marc Hellerstein, Mahalakshmi Shankaran, Edna Nyangau, Kristin L. Campbell, Catherine Lee, Alexandra M. Binder, Jeffrey A. Meyerhardt, Kathryn H. Schmitz, Elizabeth M. Cespedes Feliciano

Table 16, Subcutaneous Injection: Patients with Adverse Events

Discussion(0)

Related publications

Table 14, Intracavernosal Injection: Patients with Adverse Events

Table 26, Testosterone Treatment: Patients with Adverse Events

Table 19, Intra-urethral Treatment: Patients with Adverse Events

Table 27, Miscellaneous Treatments: Efficacy and Adverse Events

Supplementary Table 4 from Body Composition, Relative Dose Intensity, and Adverse Events Among Patients with Colon Cancer